16Indexed trials
canonical disease area
Huntington Disease
Intelligence
Huntington Disease intelligence: 16 indexed trials, 3 recruiting studies, 14 sponsors across 22 countries.
3Recruiting
14Sponsors
22Countries
Leading sponsors
CHDI Foundation, Inc.20 recruiting
Assistance Publique - Hôpitaux de Paris20 recruiting
European Huntington's Disease Network10 recruiting
First Affiliated Hospital of Fujian Medical University11 recruiting
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau11 recruiting
Massachusetts General Hospital10 recruiting
National Institute of Neurological Disorders and Stroke (NINDS)10 recruiting
Novartis Pharmaceuticals10 recruiting
Teva Branded Pharmaceutical Products R&D, Inc.10 recruiting
University College, London11 recruiting
University Hospitals Cleveland Medical Center10 recruiting
University of Rochester10 recruiting
Geographic activity
United States8trials
France5trials
Netherlands4trials
Canada4trials
Spain4trials
Sweden3trials
United Kingdom3trials
Norway3trials
Germany3trials
Italy3trials
Denmark3trials
Australia2trials
Leading interventions
ACR161trials
BioStamp nPoint device1trials
CAPIT-HD beta1trials
Divalproex1trials
Exercise training1trials
Healthy subject evaluation1trials
Huntington patient evaluation1trials
Lithium1trials
Low-Intensity Focused Ultrasound Stimulation（LIFU）1trials
PET Imaging with [18F]MNI-6591trials
PTC5181trials
Radioligand [18F]MNI-6591trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.